Skip to main content

Imvexxy News

Age at Start of Estrogen Therapy May Affect Alzheimer Disease Risk

WEDNESDAY, Sept. 24, 2025 – Estrogen therapy may reduce Alzheimer disease (AD) risk, with lower risk seen in association with early initiation, according to a study presented at the American...

Hormone Replacement Therapy Patches Safer Than Oral Delivery for Women With Diabetes

FRIDAY, Sept. 19, 2025 – Hormone replacement therapy (HRT) patches carry lower cardiovascular risk than oral HRT among women with type 2 diabetes, according to a study presented at the annual...

Type of Hormone Therapy Used After Menopause Affects Memory Performance

FRIDAY, Aug. 29, 2025 – Earlier age at menopause is associated with lower scores on all cognitive domains, and menopausal hormone therapy (MHT) differentially affects cognition, according to a study...

Use of Vaginal Estradiol Tablets Not Linked to Recurrent Stroke

THURSDAY, Aug. 21, 2025 – For women with a history of ischemic stroke, use of vaginal estradiol tablets is not associated with an increased rate of recurrent stroke, according to a study published...

Hormone Therapy Tied to Worse Bladder Health in Postmenopausal Women

TUESDAY, May 6, 2025 – Hormone therapy use is linked to worse bladder health in postmenopausal women, according to a study published online April 29 in Menopause. Camille P. Vaughan, M.D., from the ...

TherapeuticsMD Announces FDA Approval of Imvexxy (estradiol vaginal inserts) for the Treatment of Dyspareunia Due to Menopause

BOCA RATON, Fla., May 30, 2018 /PRNewswire/ – TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative women's healthcare company, today announced that the United States Food and Drug Administration (FDA)...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Atrophic Vaginitis

Imvexxy patient information at Drugs.com